PAREXEL Collaborates with Eli Lilly and Company

PAREXEL, an innovator of global biopharmaceutical services, announced a new collaboration with Eli Lilly and Company to launch a clinical research learning and development program in China which will bring training opportunities to China’s clinical trial sites and investigators.

Read the full release here.